{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:38:48Z","timestamp":1648733928911},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T00:00:00Z","timestamp":1242259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00104-008-1656-x","type":"journal-article","created":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T07:17:47Z","timestamp":1242112667000},"page":"502-507","source":"Crossref","is-referenced-by-count":1,"title":["Drug-eluting Stents"],"prefix":"10.1007","volume":"80","author":[{"given":"S.","family":"B\u00f6l\u00fckbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"J\u00e4hne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schirren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,14]]},"reference":[{"key":"1656_CR1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/bja\/ael228","volume":"97","author":"Albaladejo","year":"2006","unstructured":"Albaladejo P, Marret E, Piriou V, Samama CM (2006) Perioperative management of antiplatelet agents in patients with coronary stents: Recommendations of a French Task Force. Br J Anaesth 97:580\u2013582","journal-title":"Br J Anaesth"},{"key":"1656_CR2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.CIR.99.2.248","volume":"99","author":"Berger","year":"1999","unstructured":"Berger PB, Bell MR, Hasdai D et al (1999) Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement. Circulation 99:248\u2013253","journal-title":"Circulation"},{"key":"1656_CR3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.amjcard.2005.04.011","volume":"96","author":"Brilakis","year":"2005","unstructured":"Brilakis ES, Orford JL, Fasseas P et al (2005) Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol 96:512\u2013514","journal-title":"Am J Cardiol"},{"key":"1656_CR4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2796.2005.01477.x","volume":"257","author":"Burger","year":"2005","unstructured":"Burger W, Chemnitius JM, Kneissl GD, Rucker G (2005) Low-dose aspirin for secondary cardiovascular prevention: Cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation: Review and meta-analysis. J Intern Med 257:399\u2013414","journal-title":"J Intern Med"},{"key":"1656_CR5","first-page":"340","volume":"110","author":"Eagle","year":"2004","unstructured":"Eagle KA, Guyton RA, Davidoff R et al (2004) ACC\/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110:340\u2013437","journal-title":"Circulation"},{"key":"1656_CR6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","volume":"297","author":"Eisenstein","year":"2007","unstructured":"Eisenstein EL, Anstrom KJ, Kong DF et al (2007) Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297:159\u2013168","journal-title":"JAMA"},{"key":"1656_CR7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ahj.2005.05.003","volume":"151","author":"Fitchett","year":"2006","unstructured":"Fitchett DH, Langer A, Armstrong PW et al (2006) Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb\/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial. Am Heart J 151:373\u2013379","journal-title":"Am Heart J"},{"key":"1656_CR8","first-page":"E9052","volume":"104","author":"Fox","year":"2001","unstructured":"Fox R (2001) American Heart Association 2001 scientific sessions: Late-breaking science-drug-eluting stents. Circulation 104(21):E9052","journal-title":"Circulation"},{"key":"1656_CR9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.CIR.0000050144.67910.13","volume":"107","author":"Goodman","year":"2003","unstructured":"Goodman SG, Fitchett D, Armstrong PW et al (2003) Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb\/IIIa inhibitor eptifibatide. Circulation 107:238\u2013244","journal-title":"Circulation"},{"key":"1656_CR10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","volume":"115","author":"Grines","year":"2007","unstructured":"Grines CL, Bonow RO, Casey DE Jr et al (2007) Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 115:813\u2013818","journal-title":"Circulation"},{"key":"1656_CR11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM197907123010201","volume":"301","author":"Gruntzig","year":"1979","unstructured":"Gruntzig AR, Senning A, Siegenthaler WE (1979) Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 301:61\u201368","journal-title":"N Engl J Med"},{"key":"1656_CR12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ncpcardio0712","volume":"3","author":"Helft","year":"2006","unstructured":"Helft G, Gilard M, Le Feuvre C, Zaman AG (2006) Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Nat Clin Pract Cardiovasc Med 3(12):673\u2013680","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"1656_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2044.2004.04029.x","volume":"60","author":"Herbstreit","year":"2005","unstructured":"Herbstreit F, Peters J (2005) Spinal anaesthesia despite combined clopidogrel and aspirin therapy in a patient awaiting lung transplantation: Effects of platelet transfusion on clotting tests. Anaesthesia 60(1):85\u201387","journal-title":"Anaesthesia"},{"key":"1656_CR14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/01.CIR.0000054163.42072.D4","volume":"107","author":"Hong","year":"2003","unstructured":"Hong MK, Mintz GS, Lee CW et al (2003) Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: A Serial Volumetric Intravascular Ultrasound Analysis From the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 107:517\u2013520","journal-title":"Circulation"},{"key":"1656_CR15","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"Iakovou","year":"2005","unstructured":"Iakovou I, Schmidt T, Bonizzoni E et al (2005) Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126\u20132130","journal-title":"JAMA"},{"key":"1656_CR16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/bja\/88.2.159","volume":"88","author":"Kovesi","year":"2002","unstructured":"Kovesi T, Royston D (2002) Is there a bleeding problem with platelet-active drugs? Br J Anaesth 88:159\u2013163","journal-title":"Br J Anaesth"},{"key":"1656_CR17","unstructured":"Mehta DK (ed) (2006) British National Formulary, 51 edn. BMJ Publishing Group Ltd and RPS Publishing, London"},{"key":"1656_CR18","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jacc.2004.11.065","volume":"45","author":"Moreno","year":"2005","unstructured":"Moreno R, Fernandez C, Hernandez R et al (2005) Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45:954\u2013959","journal-title":"J Am Coll Cardiol"},{"key":"1656_CR19","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","volume":"48","author":"Pfisterer","year":"2006","unstructured":"Pfisterer M, Brunner-La Rocca HP, Buser PT et al (2006) Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48:2584\u20132591","journal-title":"J Am Coll Cardiol"},{"key":"1656_CR20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000542-200101000-00015","volume":"94","author":"Samama","year":"2001","unstructured":"Samama CM, Thiry D, Elalamy I et al (2001) Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology 94(1):74\u201378","journal-title":"Anesthesiology"},{"key":"1656_CR21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","volume":"316","author":"Sigwart","year":"1987","unstructured":"Sigwart U, Puel J, Mirkovitch V et al (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316:701\u2013706","journal-title":"N Engl J Med"},{"key":"1656_CR22","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","volume":"113","author":"Spertus","year":"2006","unstructured":"Spertus JA, Kettelkamp R, Vance C et al (2006) Prevalence, predictors and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry. Circulation 113:2803\u20132809","journal-title":"Circulation"},{"key":"1656_CR23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4065\/81.5.641","volume":"81","author":"Stone","year":"2006","unstructured":"Stone GW, Aronow HD (2006) Long-term care after percutaneous coronary intervention: Focus on the role of antiplatelet therapy. Mayo Clin Proc 81(5):641\u2013652","journal-title":"Mayo Clin Proc"},{"key":"1656_CR24","first-page":"720","volume":"47","author":"Tabuchi","year":"1998","unstructured":"Tabuchi Y, Nosaka S, Amakata Y et al (1998) Perioperative management for nephrectomy in a long-term hemodialysis patient with anticoagulants for coronary stent. Masui 47:720\u2013725","journal-title":"Masui"},{"key":"1656_CR25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jacc.2005.01.062","volume":"46","author":"Togni","year":"2005","unstructured":"Togni M, Windecker S, Cocchia R et al (2005) Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 46:231\u2013236","journal-title":"J Am Coll Cardiol"},{"key":"1656_CR26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/bja\/ael083","volume":"96","author":"Vicenzi","year":"2006","unstructured":"Vicenzi MN, Meislitzer T, Heitzinger B et al (2006) Coronary artery stenting and non-cardiac surgery: A prospective outcome study. Br J Anaesth 96:686\u2013693","journal-title":"Br J Anaesth"},{"key":"1656_CR27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(99)00005-3","volume":"83","author":"Wilson","year":"1999","unstructured":"Wilson SH, Rihal CS, Bell MR et al (1999) Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin. Am J Cardiol 83:1006\u20131011","journal-title":"Am J Cardiol"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-008-1656-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-008-1656-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-008-1656-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:23:21Z","timestamp":1558581801000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-008-1656-x"}},"subtitle":["Auswirkungen f\u00fcr chirurgische Patienten"],"short-title":[],"issued":{"date-parts":[[2009,5,14]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["1656"],"URL":"https:\/\/doi.org\/10.1007\/s00104-008-1656-x","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,14]]}}}